Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study

Condition:   Prostate Carcinoma Interventions:   Drug: Darolutamide;   Drug: Goserelin Acetate;   Drug: Leuprolide Acetate;   Drug: Placebo Administration;   Other: Quality-of-Life Assessment;   Drug: Triptorelin Sponsors:   ECOG-ACRIN Cancer Research Group;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials